925 filings
Page 18 of 47
4
LaBarre Michael J.
4 Feb 20
HALOZYME THERAPEUTICS / Michael J. LaBarre ownership change
4:24pm
4
HALO
Halozyme Therapeutics Inc.
4 Feb 20
HALOZYME THERAPEUTICS / Laurie Stelzer ownership change
4:21pm
4
Torley Helen
4 Feb 20
HALOZYME THERAPEUTICS / Helen Torley ownership change
4:18pm
5
HALO
Halozyme Therapeutics Inc.
4 Feb 20
HALOZYME THERAPEUTICS / Helen Torley ownership change
4:11pm
SC 13G/A
HALO
Halozyme Therapeutics Inc.
28 Jan 20
Beneficial ownership report (amended)
9:56am
8-K
HALO
Halozyme Therapeutics Inc.
16 Jan 20
Regulation FD Disclosure
4:25pm
8-K
HALO
Halozyme Therapeutics Inc.
14 Jan 20
Halozyme Provides 2020 Business Update and Financial Guidance
4:23pm
3
Masaru Matsuda
6 Jan 20
HALOZYME THERAPEUTICS / Masaru Matsuda ownership change
4:29pm
3
HALO
Halozyme Therapeutics Inc.
6 Jan 20
HALOZYME THERAPEUTICS / Michael J. LaBarre ownership change
4:28pm
8-K
HALO
Halozyme Therapeutics Inc.
18 Nov 19
Entry into a Material Definitive Agreement
5:02pm
8-K
HALO
Halozyme Therapeutics Inc.
14 Nov 19
Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of
6:06am
8-K/A
HALO
Halozyme Therapeutics Inc.
12 Nov 19
Cost Associated with Exit or Disposal Activities
4:26pm
10-Q
2019 Q3
HALO
Halozyme Therapeutics Inc.
Quarterly report
12 Nov 19
4:21pm
8-K
HALO
Halozyme Therapeutics Inc.
12 Nov 19
Halozyme Therapeutics, Inc. Announces Proposed Offering of $400 Million
4:15pm
8-K
HALO
Halozyme Therapeutics Inc.
12 Nov 19
Halozyme Reports Third Quarter 2019 Results
4:05pm
SC 13D/A
HALO
Halozyme Therapeutics Inc.
5 Nov 19
Beneficial ownership report (amended)
4:53pm
8-K
HALO
Halozyme Therapeutics Inc.
5 Nov 19
Cost Associated with Exit or Disposal Activities
4:36pm
4
Benjamin Hickey
1 Oct 19
HALOZYME THERAPEUTICS / Benjamin Hickey ownership change
7:10pm
8-K
HALO
Halozyme Therapeutics Inc.
4 Sep 19
Regulation FD Disclosure
11:20am
10-Q
2019 Q2
HALO
Halozyme Therapeutics Inc.
Quarterly report
6 Aug 19
4:18pm